BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18042173)

  • 1. CD8 cytotoxic T cells in cutaneous leishmaniasis.
    Ruiz JH; Becker I
    Parasite Immunol; 2007 Dec; 29(12):671-8. PubMed ID: 18042173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [CD8+ cytotoxic lymphocytes in cutaneous leishmaniasis].
    Hernández-Ruiz J; Becker I
    Salud Publica Mex; 2006; 48(5):430-9. PubMed ID: 17063826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-talk between CD8(+) and CD4(+) T cells in experimental cutaneous leishmaniasis: CD8(+) T cells are required for optimal IFN-gamma production by CD4(+) T cells.
    Herath S; Kropf P; Müller I
    Parasite Immunol; 2003; 25(11-12):559-67. PubMed ID: 15053777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8(+) T cells with parasite-specific cytotoxic activity and a Tc1 profile of cytokine and chemokine secretion develop in experimental visceral leishmaniasis.
    Tsagozis P; Karagouni E; Dotsika E
    Parasite Immunol; 2003; 25(11-12):569-79. PubMed ID: 15053778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of in situ cytotoxicity in American cutaneous leishmaniasis.
    Machado P; Kanitakis J; Almeida R; Chalon A; Araújo C; Carvalho EM
    Eur J Dermatol; 2002; 12(5):449-51. PubMed ID: 12370132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parasite-driven in vitro human lymphocyte cytotoxicity against autologous infected macrophages from mucosal leishmaniasis.
    Brodskyn CI; Barral A; Boaventura V; Carvalho E; Barral-Netto M
    J Immunol; 1997 Nov; 159(9):4467-73. PubMed ID: 9379046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages.
    Basu R; Roy S; Walden P
    J Infect Dis; 2007 May; 195(9):1373-80. PubMed ID: 17397010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin dendritic cells in murine cutaneous leishmaniasis.
    Udey MC; von Stebut E; Mendez S; Sacks DL; Belkaid Y
    Immunobiology; 2001 Dec; 204(5):590-4. PubMed ID: 11846222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the in situ inflammatory reaction an important tool to understand the cellular immune response in American tegumentary leishmaniasis?
    Morgado FN; Schubach A; Rosalino CM; Quintella LP; Santos G; Salgueiro M; Conceição-Silva F
    Br J Dermatol; 2008 Jan; 158(1):50-8. PubMed ID: 17944980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis.
    Ganguly S; Das NK; Panja M; Pal S; Modak D; Rahaman M; Mallik S; Guha SK; Pramanik N; Goswami R; Barbhuiya JN; Saha B; Chatterjee M
    J Infect Dis; 2008 Jun; 197(12):1762-71. PubMed ID: 18444882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic activity in cutaneous leishmaniasis.
    Campos TM; Costa R; Passos S; Carvalho LP
    Mem Inst Oswaldo Cruz; 2017 Nov; 112(11):733-740. PubMed ID: 29091132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copulsing tumor antigen-pulsed dendritic cells with zoledronate efficiently enhance the expansion of tumor antigen-specific CD8+ T cells via Vgamma9gammadelta T cell activation.
    Takahara M; Miyai M; Tomiyama M; Mutou M; Nicol AJ; Nieda M
    J Leukoc Biol; 2008 Mar; 83(3):742-54. PubMed ID: 18156189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly.
    Novais FO; Scott P
    Semin Immunopathol; 2015 May; 37(3):251-9. PubMed ID: 25800274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production.
    Novais FO; Carvalho AM; Clark ML; Carvalho LP; Beiting DP; Brodsky IE; Carvalho EM; Scott P
    PLoS Pathog; 2017 Feb; 13(2):e1006196. PubMed ID: 28192528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8(+) T cells mediate aortic allograft vasculopathy under conditions of calcineurin immunosuppression: role of IFN-gamma and CTL mediators.
    Nejat S; Zaki A; Hirsch GM; Lee TD
    Transpl Immunol; 2008 May; 19(2):103-11. PubMed ID: 18503885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis.
    Antonelli LR; Dutra WO; Almeida RP; Bacellar O; Carvalho EM; Gollob KJ
    Immunol Lett; 2005 Nov; 101(2):226-30. PubMed ID: 16083969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production.
    Castellano LR; Filho DC; Argiro L; Dessein H; Prata A; Dessein A; Rodrigues V
    Hum Immunol; 2009 Jun; 70(6):383-90. PubMed ID: 19480861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis.
    Silveira FT; Lainson R; De Castro Gomes CM; Laurenti MD; Corbett CE
    Parasite Immunol; 2009 Aug; 31(8):423-31. PubMed ID: 19646206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reviewing the role of the dendritic Langerhans cells in the immunopathogenesis of American cutaneous leishmaniasis.
    Silveira FT; Lainson R; Gomes CM; Laurenti MD; Corbett CE
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1075-80. PubMed ID: 18602127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.